BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 21063997)

  • 1. [Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].
    Türk Dağı H; Ozdemir M; Baykan M; Baysal B
    Mikrobiyol Bul; 2010 Jul; 44(3):467-72. PubMed ID: 21063997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].
    Uslu H; Kiki I; Ozbek A; Erdem F; Ayyildiz A
    Mikrobiyol Bul; 2007 Oct; 41(4):597-602. PubMed ID: 18173080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].
    Wei Q; Li Y; Wang JW; Wang H; Qu JG; Hung T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):60-2. PubMed ID: 16816866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis.
    Weissbrich B; Süss-Fröhlich Y; Girschick HJ
    Arthritis Res Ther; 2007; 9(4):R82. PubMed ID: 17760961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related immunoglobulin G seroprevalence of human parvovirus B-19 in Israeli children.
    Miron D; Horovitz Y; Luder A; Ohnona FS; Schlesinger Y
    Isr Med Assoc J; 2010 May; 12(5):277-9. PubMed ID: 20929079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of parvovirus B19 infection in women of childbearing age in England and Wales.
    Vyse AJ; Andrews NJ; Hesketh LM; Pebody R
    Epidemiol Infect; 2007 Nov; 135(8):1354-62. PubMed ID: 17291377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Seroprevalence of anti-human parvovirus B19 antibodies in a sample of blood donors in Galicia].
    Mata Rebón M; Bartolomé Husson C; Bernárdez Hermida I
    Enferm Infecc Microbiol Clin; 1998 Jan; 16(1):25-7. PubMed ID: 9542305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute human parvovirus B-19 infection in hospitalized children: A serologic and molecular survey.
    Miron D; Luder A; Horovitz Y; Izkovitz A; Shizgreen I; Ben David E; Ohnona FS; Schlesinger Y
    Pediatr Infect Dis J; 2006 Oct; 25(10):898-901. PubMed ID: 17006284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
    Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
    J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Seroprevalence of human parvovirus B 19 antibodies (Sticker's disease/erythema infectiosum) in the DRG population].
    Wiersbitzky S; Schwarz TF; Bruns R; Jäger G; Bittner S; Weidemann H; Deinhardt F; Hottenträger B; Abel E; Ladstätter L
    Kinderarztl Prax; 1990 Apr; 58(4):185-9. PubMed ID: 2164118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parvovirus B19 infection in Hong Kong.
    Lim WL; Wong KF; Lau CS
    J Infect; 1997 Nov; 35(3):247-9. PubMed ID: 9459396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low seroprevalence of parvovirus B19 in Taiwanese children and young adults.
    Su WJ; Ni YH; Liu DP; Chiou LS; Cheng WY; Wu JS; Lu CY
    Pediatr Neonatol; 2010 Oct; 51(5):265-8. PubMed ID: 20951355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human parvovirus B19 in Iranian pregnant women: a serologic survey.
    Khameneh ZR; Hanifian H; Barzegari R; Sepehrvand N
    Indian J Pathol Microbiol; 2014; 57(3):442-4. PubMed ID: 25118740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria.
    Abiodun I; Opaleye OO; Ojurongbe O; Fagbami AH
    J Infect Dev Ctries; 2013 Dec; 7(12):946-50. PubMed ID: 24334941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of indirect immunofluorescence (IIF) and ELISA techniques in the detection of parvovirus B19].
    González M; Hassanhi M; Rivera S; Bracho MP
    Invest Clin; 2000 Mar; 41(1):19-27. PubMed ID: 10758696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of human parvovirus B19 in cancer patients using ELISA and real-time PCR.
    Zaki SA
    Indian J Med Microbiol; 2012; 30(4):407-10. PubMed ID: 23183464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].
    Ataman S; Colak D; Günseren F; Senol Y; Colak T; Aktekin MR; Gültekin M
    Mikrobiyol Bul; 2007 Oct; 41(4):545-55. PubMed ID: 18173073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antibodies to parvovirus B 19 in Thailand.
    Poovorawan Y; Theamboonlers A; Suandork P; Hirsch P
    Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):422-4. PubMed ID: 11127352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased seroprevalence of parvovirus B 19 IgG in complex regional pain syndrome is not associated with antiendothelial autoimmunity.
    Gross O; Tschernatsch M; Bräu ME; Hempelmann G; Birklein F; Kaps M; Madlener K; Blaes F
    Eur J Pain; 2007 Feb; 11(2):237-40. PubMed ID: 16545972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.